XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Income Statement [Abstract]        
Research and development $ (1,953) $ (1,389) $ (5,852) $ (3,897)
General and administrative (1,521) (1,163) (4,361) (3,523)
Operating loss (3,474) (2,552) (10,213) (7,420)
Financing income (expenses), net 6 (3) 43 (34)
Net loss $ (3,468) $ (2,555) $ (10,170) $ (7,454)
Basic and diluted net loss per share $ (0.49) $ (0.36) $ (1.43) $ (1.05)
Basic and diluted weighted average common shares outstanding 7,108,133 7,108,133 7,108,133 7,108,133